Visx tries to fend off Icahn's latest attentions
This article was originally published in Clinica
Executive Summary
After a period of calm, financier Carl Icahn has renewed his assault on Californian laser eye surgery firm Visx. The Santa Clara company is once again opposing a bid by its major shareholder to gain representation on its board of directors.